Efficacy and Safety of Crisugabalin with Acetyl-Levo-Carnitine in Chinese Patients with Diabetic Peripheral Neuropathic Pain-A Multicentre, Randomized, Open-Label, Positive-Controlled, Parallel-Group, Phase 2 Trial

被引：0
|
作者：
Jiang, Hongwei
Fu, Liujun
Xu, Na
Shang, Junjie
Yang, Qiuwei
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-868-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
868-P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3trial
    Harrison, Claire N.
    Mesa, Ruben
    Talpaz, Moshe
    Al-Ali, Haifa Kathrin
    Xicoy, Blanca
    Passamonti, Francesco
    Palandri, Francesca
    Benevolo, Giulia
    Vannucchi, Alessandro Maria
    Mediavilla, Clemence
    Iurlo, Alessandra
    Kim, Inho
    Rose, Shelonitda
    Brown, Patrick
    Hernandez, Christopher
    Wang, Jia
    Kiladjian, Jean-Jacques
    LANCET HAEMATOLOGY, 2024, 11 (10): : e729 - e740
  • [42] Low-Dose Buprenorphine Initiation for Hospitalized Patients With Chronic Pain and Opioid Use Disorder or Opioid Misuse: Protocol for an Open-Label, Parallel-Group, Effectiveness-Implementation Randomized Controlled Trial
    Hayes, Benjamin T.
    Fat, Guillermo Sanchez
    Torres-Lockhart, Kristine
    Khalid, Laila
    Minami, Haruka
    Ghiroli, Megan
    Hribar, Mary Beth
    Pacifico, Jessica
    Bao, Yuhua
    Rodgers, Caryn R. R.
    Gabbay, Vilma
    Starrels, Joanna
    Fox, Aaron D.
    SUBSTANCE USE & ADDICTION JOURNAL, 2025, 46 (01): : 184 - 191
  • [43] Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial
    Kook, Hyungdon
    Yu, Cheol Woong
    Choi, Donghoon
    Ahn, Tae Hoon
    Chang, Kiyuk
    Cho, Jin-Man
    Kim, Soo-Joong
    Park, Chang Gyu
    Cho, Deok-Kyu
    Kim, Sang-Hyun
    Lee, Han Cheol
    Jin, Han-Young
    Chae, In-Ho
    Kwon, Kihwan
    Ahn, Sung Gyun
    Kim, Ju Han
    Lee, Sang-Rok
    Kim, Jeong-Su
    Kim, Seok Yeon
    Lim, Sang Wook
    CLINICAL THERAPEUTICS, 2022, 44 (04) : 508 - +
  • [44] Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison
    Wang, Jun-Sing
    Lin, Shi-Dou
    Lee, Wen-Jane
    Su, Shih-Li
    Lee, I-Te
    Tu, Shih-Te
    Tseng, Yao-Hsien
    Lin, Shih-Yi
    Sheu, Wayne Huey-Herng
    CLINICAL THERAPEUTICS, 2011, 33 (12) : 1932 - 1942
  • [45] Effects of pregabalin on pain and nerve conduction in patients with painful diabetic peripheral neuropathy (DPN): a 13-week randomized controlled trial and 6-month open-label safety extension
    Arezzo, J.
    Rosenstock, J.
    LaMoreaux, L.
    Pauer, L.
    Sharma, U.
    DIABETOLOGIA, 2007, 50 : S471 - S471
  • [46] Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
    Shapiro, Amy
    Castaman, Giancarlo
    Cepo, Katarina
    Poulsen, Lone Hvitfeldt
    Hollensen, Christian
    Matsushita, Tadashi
    Young, Guy
    Zupancic-Salek, Silva
    Jimenez-Yuste, Victor
    BLOOD, 2019, 134
  • [47] EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock—a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial
    Sascha David
    Christian Bode
    Klaus Stahl
    Trials, 24
  • [48] Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial (vol 23, pg 117, 2023)
    Wedemeyer, H.
    Schoneweis, K.
    Bogomolov, P.
    LANCET INFECTIOUS DISEASES, 2022, 22 (12): : E348 - E348
  • [49] Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
    Mell, Loren K.
    Torres-Saavedra, Pedro A.
    Wong, Stuart J.
    Kish, Julie A.
    Chang, Steven S.
    Jordan, Richard C.
    Liu, Tian
    Truong, Minh Tam
    Winquist, Eric W.
    Takiar, Vinita
    Wise-Draper, Trisha
    Robbins, Jared R.
    Rodriguez, Cristina P.
    Awan, Musaddiq J.
    Beadle, Beth M.
    Henson, Christina
    Narayan, Samir
    Spencer, Sharon A.
    Powell, Steven
    Dunlap, Neal
    Sacco, Assuntina G.
    Hu, Kenneth Shung
    Park, Henry S.
    Bauman, Julie E.
    Harris, Jonathan
    Yom, Sue S.
    Le, Quynh-Thu
    LANCET ONCOLOGY, 2024, 25 (12): : 1576 - 1588
  • [50] Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial
    Haitham G. Zakaraia
    Heba F. Salem
    Mostafa A. A. Mostafa
    Ahmed M. Ali
    Hoda M. Rabea
    Beni-Suef University Journal of Basic and Applied Sciences, 12
12345